These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6546966)

  • 1. [3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
    Baĭsogolov GD; Shakhtarina SV
    Med Radiol (Mosk); 1984 Apr; 29(4):46-50. PubMed ID: 6546966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
    Tsyplenkov VG; Sviridova AV
    Med Radiol (Mosk); 1984 Oct; 29(10):34-7. PubMed ID: 6548787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
    Baĭsogolov GD; Shakhtarina SV; Afanasova NV
    Med Radiol (Mosk); 1991; 36(8):4-7. PubMed ID: 1890940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
    Demina EA; Kondrat'eva NF; Pirogova NA
    Ter Arkh; 1991; 63(7):40-4. PubMed ID: 1788806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of treatment using expanded programs of megavolt irradiation and polychemotherapy in patients with lymphogranulomatosis in stages I, II and IIIA].
    Mendeleev IM; Oleĭnik VA; Miasnikov AA; Polezhaev IuN
    Ter Arkh; 1990; 62(7):67-70. PubMed ID: 2123574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The polychemotherapy and combined treatment of patients with stage-I and -II lymphogranulomatosis and unfavorable prognosis].
    Demina EA; Kaverzneva MM; Kondrat'eva NF; Agafonov VA
    Ter Arkh; 1990; 62(7):72-5. PubMed ID: 2251669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnosis and treatment of lymphogranulomatosis in children].
    Atamanov IuA; Malikov AA; Golovkina NM; Romantsova LA; Silinskaia NV
    Vopr Onkol; 1991; 37(9-10):988-91. PubMed ID: 1842663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patients with lymphogranulomatosis, stages I and II (preliminary results of a randomized study--radiation and complex therapy)].
    Blokhina NG; Aliev BM; Kruglova GV; Kaverzneva MM; Vasygova NF
    Vestn Akad Med Nauk SSSR; 1985; (1):45-9. PubMed ID: 3883672
    [No Abstract]   [Full Text] [Related]  

  • 11. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
    J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
    J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 15. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
    Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
    Baĭsogolov GD; Afanasova NV; Shakhtarina SV
    Med Radiol (Mosk); 1990 May; 35(5):10-3. PubMed ID: 2342405
    [No Abstract]   [Full Text] [Related]  

  • 19. [A combined therapy program for children with lymphogranulomatosis].
    Poliakov VE; Ankudinov VA; Tsygankin VI; Makhonova LA
    Pediatriia; 1984 Feb; (2):34-7. PubMed ID: 6546987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.